H01.123
Discoid lupus erythematosus of right eye, unspecified eyelid
Clinical Classification Guidelines
Medical Intelligence & Overview
Discoid lupus erythematosus (DLE) is a chronic autoimmune skin condition that primarily affects the skin, leading to inflammation and scarring. When it involves the eyelids, especially the right eye as specified by ICD-10 Code H01.123, it can cause changes to the skin and tissues around the eye. This condition is a localized form of lupus, distinct from systemic lupus erythematosus, as it mainly impacts the skin rather than affecting internal organs. Recognizing the signs and understanding the potential implications of DLE involving the eyelid can be important for proper management and eye health.
Causes & Symptoms
Clinical Causes: Autoimmune response where the body's immune system attacks healthy skin tissues. Genetic predisposition that may increase susceptibility to autoimmune diseases. Environmental factors such as ultraviolet (UV) exposure can trigger flare-ups. Potential role of hormonal factors, especially in women. Certain medications or chemicals might exacerbate or trigger the condition.
Key Symptoms: Red, scaly patches on the eyelid, often with well-defined borders. Increased pigmentation or discoloration in affected areas. Thickening or scarring of the skin on the eyelid. Feeling of dryness or irritation around the eye. Possible swelling or sensitivity in the affected eyelid. In some cases, the affected skin may develop a shiny or atrophic appearance.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a clinical examination by a healthcare professional, who evaluates the characteristic skin changes around the eye. A skin biopsy may be performed to confirm the diagnosis, where a small skin sample is examined microscopically for characteristic features of discoid lupus. Additional tests might include immunofluorescence studies or blood tests to rule out systemic lupus erythematosus, although DLE is generally localized. Visual assessment and eye examination are also important to determine any impact on eye health and function.
Treatment Protocols: Management of discoid lupus erythematosus affecting the eyelid often involves a combination of treatments aimed at controlling inflammation and preventing scarring. These may include: - Topical corticosteroids or other anti-inflammatory medications to reduce skin inflammation. - Sun protection measures, including wearing sunglasses and using broad-spectrum sunscreens, to prevent UV-triggered flare-ups. - Avoidance of known triggers such as harsh chemicals or excessive sun exposure. - In some cases, systemic medications like antimalarials (e.g., hydroxychloroquine) may be prescribed for more severe or resistant cases. - Regular monitoring by healthcare professionals to assess skin healing and manage any complications. Since DLE can leave scars or cause skin pigment changes, early treatment and ongoing care are important to minimize long-term effects.
Clinical Advice & FAQs
Billing Guidance
Is H01.123 a billable ICD-10 code?
Yes, H01.123 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H01.123?
Clinical documentation must specify the nature of Discoid lupus erythematosus of right eye, unspecified eyelid and any associated comorbidities for accurate reporting.
Cite this Clinical Reference